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Aging is characterized by a general decline in cellular function, which ultimately will affect whole body
homeostasis. Although DNA damage and oxidative stress all contribute to aging, metabolic dysfunction is a
commonhallmark of aging at least in invertebrates. Since a comprehensive overview ofmetabolic changes in
otherwise healthy aging mammals is lacking, we here compared metabolic parameters of young and 2 year
old mice. We systemically integrated in vivo phenotyping with gene expression, biochemical analysis, and
metabolomics, thereby identifying a distinguishing metabolic footprint of aging. Among the affected
pathways in both liver and muscle we found glucose and fatty acid metabolism, and redox homeostasis.
These alterations translated in decreased long chain acylcarnitines and increased free fatty acid levels and a
marked reduction in various amino acids in the plasma of aged mice. As such, these metabolites serve as
biomarkers for aging and healthspan.
A
ging (and ultimately death) is an inevitable part of life and comes with all sorts of physical and mental
ailments, including common metabolic, inflammatory, cardiovascular and neurodegenerative diseases,
whichwill reduce healthspan. Examples of such diseases include Parkinson’s andAlzheimer’s disease, and
from a cardiometabolic perspective, obesity, type 2 diabetes, and atherosclerosis. Even though these clinical
manifestations are well known, the complex biomolecular networks contributing to the aging process are only
beginning to be uncovered1. Several common processes are suggested to cause or at least contribute to aging,
including DNA damage, accumulation of reactive oxygen species (ROS), and general metabolic dysfunction. So
far, these were mostly seen as independent events, but evidence suggests that some of these pathways are
interconnected, as recently highlighted by the link between DNA damage and metabolic control2,3.
Regardless of the mechanism, a common feature of aging-related disease is the involvement of metabolic
systems in general, and the mitochondria in particular1,4–6. The best-characterized metabolic pathway implicated
in aging is the insulin/IGF1 signaling pathway7. Both the C. elegans and D. melanogaster mutants of insulin
receptor showed increased lifespan and the effect is mediated through the FOXO1 transcription factor, the heat-
shock factor HSF1, and SKN1 (reviewed in5). Involvement of the insulin/IGF1 pathway in mammalian lifespan
regulation is debated but seems likely7. A second longevity pathway is centered on the mammalian target of
rapamycin (mTOR), which integrates insulin signaling with sensing of other nutrients —most notably amino
acids— and as such regulates protein translation and autophagy8,9. In line with this, mTOR was shown to be
involved in the aging-associated decrease in ketone body production10 and inhibition ofmTOR by administration
of rapamycin increased mouse lifespan11. Opposing these nutrient excess systems are the nutrient restriction
pathways, such as the sirtuin and AMP-activated protein kinase (AMPK) pathways12,13. Being activated by energy
stress, for instance after prolonged fasting or exercise, they inhibit energy-demanding processes in favor of
energy-production14. Both sirtuins and AMPK have been suggested as positive regulators of longevity in lower
organisms (discussed in1), but as for the insulin/IGF1 pathway, convincing involvement in mammalian longevity
needs to be confirmed. In C. elegans, AMPK was shown to directly phosphorylate the CREB-regulated transcrip-
tional coactivator-1, which then becomes unable to coactivate the CREB transcription factor to decrease life-
span15, indicating an aging pathway that could be conserved in mammals. Additionally, in mouse, AMPK has
been connected with SIRT116,17 and PGC-1a signaling17,18 consolidating the link of this systemwithmitochondrial
metabolism, notably mitochondrial respiration. It is still debated, however, how mitochondrial function impacts
aging, as both inhibiting and stimulating mitochondrial metabolism seems to enhance lifespan (discussed in1,5).
Most likely, the physiological context and the nature of themanipulation itself may determine the aging response.
This phenotype seems at least partly mediated by the mitochondrial unfolded protein response and acts in a cell-
non-autonomous fashion involving a yet unidentified ‘‘mitokine’’19.
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Several studies have reported the molecular effects of aging, for
instance at the biochemical20, genomic21, or metabolomic level22. The
limitation of these studies, however, lies in the problems with the
multilevel integration of these different datasets. We therefore aimed
to obtain an unbiased map and understand the metabolic decline
during aging that predisposes to aging-related diseases in mammals.
We characterized clinical, molecular and metabolomic aspects of
aging in wild type C57BL/6J mice—the most commonly used strain
for metabolic studies. This enabled us to define a consensus pheno-
type of aging by identifying metabolite sets and molecular changes
that can be used as healthspan biomarkers and thereby constitute the
detailed metabolic footprint of aging.
Results
Metabolic characterization and physical performance. To char-
acterize metabolic changes during mammalian aging, we employed
C57BL/6J mice of 3 months (‘‘young’’) and 22 months (‘‘old’’). We
validated our agingmodel through an extensive clinical phenotyping
effort. As expected, aged mice showed signs of physiological decline.
Old mice are significantly heavier than young mice (Fig 1A), mostly
because of an increase in fat mass (Fig 1B). Furthermore, old mice
developed discrete glucose intolerance, reflecting potentially the
development of insulin resistance (Supplementary Fig S1 online).
In indirect calorimetry old mice had a tendency to decreased energy
expenditure when corrected for lean body mass (Fig 1C) or when
compared with multiple regression (p50.128), likely in part due to
decreased physical activity (Supplementary Fig S1 online). The res-
piratory exchange ratio (RER) in old mice was lowered compared to
youngmice, indicating that aging mice have a proportional substrate
preference towards fat (Fig 1C). When challenged with a physical
exercise, maximum VO2 was significantly decreased (Fig 1D)
The decreased physical activity in old mice during indirect calori-
metry, was confirmed in a home-cage monitoring, during which
mice had free access to a running wheel (Fig 1E). Old mice ran less
both during the initial discovery phase and at later stages during the
night phase. This hypodynamic phenotype in the old mice was also
observed in a square open field test, which showed the old mice to be
less agile than the youngmice (Supplementary Fig S1 online). Catwalk
analysis —used to determine gait disturbances inmice— revealed that
the time standing on one paw before taking the next step is signifi-
cantly increased with age (Supplementary Fig S1 online).
Molecular and biochemical alterations in aging tissues.Molecular
characterization of tissues of the aged mice confirmed the view
of metabolic —notably mitochondrial— decline that is thought to
underlie part of the aging process. In gastrocnemius muscle, brown
adipose tissue (BAT) and liver, we observed a drop in expression of a
variety of transcripts encoding proteins involved in oxidative phos-
phorylation (Ndufa2, Ndufb3, Cyt c, Cox IV, Atp5g1, Ucp3), fatty acid
oxidation (FAO) (Cpt1b, Acadm, Acadl), mitochondrial biogenesis
(Tfam), oxidative stress defense (Sod2), and apoptosis (Bax) (Fig 1F,
Supplementary Fig S1 online). Further validating the fact that our
study captured mainly aging-associated changes was the fact that the
gene expression data were fully consistent with a previously pub-
lished survey of C57BL/6N gastrocnemius muscle gene expression
comparing 5 and 25-month-old mice21 (Supplementary Fig S1
online). Interestingly, in this dataset the decreased expression of
many genes involved in oxidative phosphorylation (e.g. Atpaf2,
Cox4i2), FAO (e.g. Cpt1b, Acads), and oxidative stress defense
(Sod2) was reverted by caloric restriction (CR), the only physiological
intervention increasing lifespan known to date (Supplementary Fig
S1 online). In contrast, expression of various antioxidants (Gpx3,
Gpx4, Gpx6) was increased in old mice and normalized in CR mice
(Supplementary Fig S1 online).
Although the expression of nuclear genes encoding mitochondrial
proteins was generally decreased, some were unchanged (e.g. Acadl
and Atp5g1 in gastrocnemius, and Mfn2 and Cpt1a in liver), and
in BAT the expression of several genes increased with age (Tfam,
Mfn2, Pgc-1a, Cox IV) (Fig 1F, Supplementary Fig S1 online). We
Figure 1 | Clinical and molecular phenotyping of aging mice. (A) Body weight. (B) Body composition. (C) Indirect calorimetry shows oxygen
consumption (VO2) and respiratory exchange ratio (RER) during 24h recording. (D)Basal andmaximumVO2 on ametabolic treadmill. (E) Twenty-four
hours voluntary exercise recording. (F) Gene expression of young and old mice in gastrocnemius muscle (G) Enzymatic activity of citrate synthase (CS),
and complex I and complex IV of oxidative phosphorylation in gastrocnemiusmuscle. (H)Western blot analysis of relevantmetabolic signaling pathways
in gastrocnemiusmuscle. pAMPKa represents phosphorylation/activation of the a-subunit of AMPK; Immunoprecipitated IRS1 was used tomeasure its
phosphorylation on serine residues (p-Ser); p-S6K1 reflects S6K1 phosporylation/activation. Tubulin is used as a loading control. Values are expressed as
mean6SEM; n56–10 (Fig 1A, n520). * p#0.05; ** p#0.01; *** p#0.001.
www.nature.com/scientificreports
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hypothesized that this is due to compensatory mechanisms that are
activated in old mice to maintain proper mitochondrial function.
Another line of evidence for possible compensatory mechanisms to
maintain mitochondrial capacity comes from enzyme activity ana-
lysis. Both in muscle and liver, citrate synthase (CS) activity was
increased in the oldmice, indicating increasedmitochondrial activity
or number (Fig 1G, Supplementary Fig S1 online). In contrast, rela-
tive activity of complex I and IV was equal between the two age
groups (Fig 1G, Supplementary Fig S1 online). The increased CS
activity in muscle and liver is not derived from mitochondrial bio-
genesis, as mitochondrial DNA (mtDNA) quantification in these
tissues revealed no changes (Supplementary Fig S1 online). In BAT,
however, an increase inmtDNAwas observed (Supplementary Fig S1
online) following the increased gene expression of among others
Tfam and Pgc-1a (Supplementary Fig S1 online). Deterioration of
mitochondrial function is often reflected in increased levels of ROS.
We therefore measured ROS damage, by virtue of 4-hydroxynonenal
(4-HNE)—amarker for lipid peroxidation. As expected, oldmice had
increased levels of 4-HNE in muscle as well as liver (Supplementary
Fig S1 online).
Signaling pathways in aging. To complement our gene expression
and enzyme activity data, we also assessed metabolic signaling path-
ways, focusing on established metabolic regulation pathways linked
to aging. In the old livers and muscles, insulin receptor substrate 1
(IRS-1) serine phosphorylation, which is a marker for insulin resist-
ance, was increased, although to a different extent in the two tissues
(Fig 1H, Supplementary Fig S1 online). In both liver andmuscle, p70
S6 kinase phosphorylation was markedly decreased (Fig 1H,
Supplementary Fig S1 online), reflecting decreased mTOR activity,
possibly consequent to impaired insulin signaling, as suggested by
the higher IRS-1 serine phosphorylation and reduced Akt phos-
phorylation. In addition to these nutrient excess pathways, we also
analyzed the expression and activity of the nutrient restriction sensor
AMPK and found that its phosphorylation, indicative for energy
stress, was not changed in liver and muscle of old mice (Fig 1H,
Supplementary Fig S1 online).
Metabolic disturbances in blood. To further characterize the meta-
bolic changes upon aging, we performed clinical chemistry analysis
in plasma. Various changes in plasma markers were noted, such as
increased free fatty acid and decreased triglyceride levels (Fig 2A, C).
To expand our characterization of blood metabolites in aging mice
and to identify possible novel aging biomarkers we took a less tar-
geted approach and generated an extensive metabolomics profile in
the blood of young and old mice. Over 75 analytes including profiles
of erythrocyte fatty acids and plasma acylcarnitines, amino acids and
ketone bodies were measured and these data were clustered in order
to identify groups of metabolites that respond similarly during aging
(Fig 2B–C). Using this profile ofmetabolites, themice were separated
out according to age and several interesting metabolite clusters
became apparent. One of these clusters contained long chain as well
as medium chain acylcarnitines. These metabolites, which are inter-
mediates of FAO, were decreased in the old mice (Fig 2C). The
erythrocyte fatty acid profile reflects long-term changes in fatty acid
homeostasis and is routinely performed for the diagnosis of poly-
unsaturated fatty acid (PUFA) deficiency. For the saturated fatty
acids, C16 was slightly decreased whereas the elongated C18 and
C20 were increased. In addition, various intermediates and products
of PUFA biosynthesis such as C20:4v6 were increased, whereas the
substrates C18:2v6 and C18:3v3 were decreased. Overall levels of
PUFAs as well as plasmalogens, which both have been implicated in
protection against ROS, were not decreased (Fig 2B).
In addition to fat metabolism, amino acid metabolism also alters
significantly during aging. It was shown before that supplementation
of branched-chain amino acids (BCAAs)23 or alteration in methio-
nine content in the diet24,25 impacts lifespan. Our characterization of
the plasma amino acids associated a clear reduction in the levels of
proline, alanine, serine, tyrosine and methionine with aging but not
in the levels of the BCAAs valine, leucine and isoleucine (Fig 2B–C).
Figure 2 | Plasma biochemistry and targeted metabolomics. (A) Two-way hierarchical clustering of plasma clinical biochemistry. (B) Two-way
hierarchical clustering of targetedmetabolomics data. Metabolites described by FA are erythrocyte fatty acids, whereas ACs denote plasma acylcarnitines.
(C) Plasma levels of selected metabolites. Values are expressed as box-and-whisker plots; n510; * p#0.05; ** p#0.01; *** p#0.001.
www.nature.com/scientificreports
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Similarly, it was previously shown that the mTOR pathway inhibits
ketogenesis and that ketogenic capacity is reduced in aging10. In line
with decreased ketogenesis, our analysis found that b-hydroxybuty-
rate (BHBA) levels, which reflect total ketone body levels, tended to
decrease with age (Fig 2C).
Novel biomarkers of aging. The clear differences in plasma meta-
bolite levels between young and old mice led us to test whether these
can be used to discriminate the two groups reliably, a prerequisite for
biomarker development.
Selection of relevant variables for sample classification is a com-
mon task with high dimensional data sets such as metabolomics and
gene expression studies where one tries to identify the smallest pos-
sible set of metabolites or genes (i.e. biomarkers) that can still achieve
good predictive performance. Random Forest (RF) is one such learn-
ing algorithm that can do this by estimating the importance of each
variable to the classes. RF analysis generates many classification trees
using a random training set of mice and a random small selection of
metabolites. Mice that are left out of the tree are used to estimate the
classification error providing an internal cross validation. As such,
the ‘‘mean decrease accuracy’’ indicates how much a certain meta-
bolite contributes to separation of the two test groups, and the overall
‘‘predictive accuracy’’ indicates the accuracy with which a set of
metabolites combined can separate the groups. RF analysis of
blood targeted metabolomics data defined a set of 10 metabolites
that constitute the best predictors of aging, with a 100% predictive
accuracy (Fig 3A). In particular, decreased erythrocyte linoleic
acid (C18:2v6) and decreased plasma C16-acylcarnitine were strong
predictors (Fig 3B).
Following these clear metabolic changes in our blood metabolite
analysis and microarray data, we also charted metabolic changes in
both liver and quadriceps muscle of young and old mice using global
metabolomics. We detected 473 and 263 metabolites in liver and
muscle, respectively, of which 94 and 65 were significantly changed
between the groups (see Supplementary tables S1 and S2 online for
relative metabolite levels). We again performed RF analysis to clas-
sify these metabolic changes (Fig 4–5). In liver, the metabolite
changes could 93% accurately predict the age groups (Fig 4A) and
hierarchical clustering of the top 25 metabolites confirmed the sepa-
ration of the two age groups (Fig 4B). Following RF analysis, which
was aimed to identify relative contribution of individual metabolites
from the high-dimensional metabolomics data, we performed meta-
bolite set enrichment analysis (MSEA)26 to establish which pathways
are affected. In liver, the best metabolites to predict age were in
glucose metabolism, phospholipid metabolism, and redox home-
ostasis (Fig 4C). Additionally, we performed a metabolome view
analysis to demonstrate whether a metabolite ‘hub’ node was affec-
ted, which could havemore biological consequences than a ‘deadend’
metabolite node, confirming that mainly carbohydrate and glycer-
olipid metabolism, and redox balance were disturbed (Fig 4C). With
respect to redox homeostasis, for example, various metabolites were
changed in oldmice, notably the metabolite hub reduced glutathione
(Supplementary Fig S2 online).
In muscle, the top 25 is dominated by fatty acid metabolites
(Fig 5A), with the top 20 set already showing a predictive accuracy
of 100% and clear group separation (Fig 5B).MSEA andmetabolome
view confirmed involvement of fatty acid metabolism, but also
highlighted a strong contribution of glucose metabolism, with
Figure 3 | Metabolite and pathway enrichment of targetedmetabolomics andmicroarray. (A) To relate aging status to the bloodmetabolite expression
data, we used random forest predictors. A random forest importance measure was used to rankmetabolites according to their prognostic importance for
aging status.We find that the 10 most important metabolites lead to an apparent predictive accuracy of 100%. (B) Supervised hierarchical clustering plot
for visualizing the expression of the RF predictors (z-score normalized). The RF plot and the supervised hierarchical clustering plot show that the 15most
important metabolites stratify the samples according to their aging status. Metabolites described by FA are erythrocyte fatty acids, whereas ACs denote
plasma acylcarnitines. A color code describes the pathway to which the respective metabolite belongs.
www.nature.com/scientificreports
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Figure 4 | Aging biomarker identification and pathway analysis by globalmetabolomics in liver. To relate aging status to the livermetabolite expression
data, we used random forest predictors (A). Metabolites were ranked according to their increasing importance to group separation according to age. We
find that the 25 andmost important probesets lead to an apparent predictive accuracy of 93%. Colored symbols are used to indicate the pathways in which
themetabolites play a role. Supervised hierarchical clustering plot (B) for visualizing the expression of the RF predictors (z-score normalized). The RF plot
and the supervised hierarchical clustering plot show that the 25 most important metabolites stratify the samples according to their aging status. (C)
Summary plot for metabolite set enrichment analysis (MSEA) (left panel) where metabolite sets are ranked according to Holm p-value with hatched lines
showing the cut off of Holm p-value. Metabolome view (right panel) reflects on the x-axis increasing metabolic pathway impact according to the
betweenness centrality measure, which reflects key nodes in metabolic pathways that have been significantly altered with aging.
www.nature.com/scientificreports
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Figure 5 | Aging biomarker identification and pathway analysis by global metabolomics in muscle. To relate aging status to the muscle metabolite
expression data, we used random forest predictors (A). Metabolites were ranked according to their increasing importance to group separation according to
age.We find that the 25 andmost important probesets lead to an apparent predictive accuracy of 100%.Colored symbols are used to indicate the pathways in
which themetabolites play a role. Supervised hierarchical clustering plot (B) for visualizing the expression of the RF predictors (z-score normalized). The RF
plot and the supervised hierarchical clustering plot show that the 25 most important metabolites stratify the samples according to their aging status. (C)
Summary plot for metabolite set enrichment analysis (MSEA) (left panel) and metabolome view (right panel) as discussed in Figure 4C.
www.nature.com/scientificreports
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metabolism of the poly-unsaturated fatty acids linolenic and linoleic
acid being the best predictors of age in muscle (Fig 5A,
Supplementary Fig S3 online). These metabolites serve as hubs in
poly-unsaturated fatty acid metabolism and therefore have a high
impact on predictive power (Supplementary Fig S3 online).
Discussion
Aging and the diseases associated with it are a heavy burden on
society. The current increase in life expectancy not only impacts
on our social systems, but also goes hand in hand with the emergence
of common chronic diseases, including those of the nervous,
immune, and cardio-metabolic systems, which often reach epidemic
proportions. In this respect it is important to understand the natural
aging process and to elucidate where lifestyle and/or pharmaco-
logical interventions can have an impact. In recent years, many novel
therapeutic options have been suggested to prevent aging-associated
disease. Although some of these pharmaceutical interventions were
shown to extend lifespan, even in mammals11,27, there is no good
readout for improved healthspan as aging biomarkers have not been
identified.
Here, we characterized clinical as well as molecular, biochemical,
andmetabolomic alterations in young versus oldmice, thereby defin-
ing a consensus phenotype of aging. Besides metabolomics in blood
and plasma, we also performed an unbiased approach to determine
metabolic changes in muscle and liver. We used C57BL/6J mice, as
these are particularly suitable for studying metabolic disease28,29. We
realize that our study could be biased by the changes in body com-
position that accompany aging, but this phenomenon is inherent to
aging in all species. Although it could be argued that an aging model
devoid of changes in fat mass or glucose homeostasis would be
optimal, such a model does not exist, as physiological decline is a
hallmark of aging.
The compendium that we generated of the changes occurring in
naturally aging mice highlighted a wide variety of molecular and
metabolic changes. Our data suggest strong involvement of impaired
mitochondrial function. Not only did we observe a marked decrease
in expression of various transcripts involved in mitochondrial func-
tion—e.g. oxidative phosphorylation, FAO, apoptosis—, but also we
measured changes in enzymatic activity, altogether possibly culmin-
ating in the accumulation of oxidative damage, as evidenced by ele-
vated 4-HNE levels. This coincided with the identification of redox
homeostasis and its hub glutathione as affected pathways in our liver
and muscle metabolomic analysis, suggesting that reactive oxygen
species play a role in the initiation or progression of the aging pheno-
type. Interestingly, the lowered gene expression and oxidative phos-
phorylation activity in various tissues seems to be counteracted by a
compensatory increase in mitochondrial biogenesis and/or activity,
as CS in muscle and mtDNA abundance in BAT are increased in
old mice.
From a signaling perspective, the insulin and mTOR pathways
were affected. Increased IRS-1 serine phosphorylation is linked to
insulin resistance30, a signature of aging that was also observed in our
study (Supplementary Fig S1 online). IRS-1 serine phosphorylation
impedes its proper association with the insulin receptor and, there-
fore, the ability of insulin to promote IRS-1 tyrosine phosphorylation
and activate Akt and PI3-kinase and its downstream pathways31–33.
Consistent with this, S6K1 phosphorylation was reduced in tissues
from old mice. S6K1 phosphorylation depends on mTOR, which is
coordinately activated by nutrients and PI3-kinase34. Serine phos-
phorylation of IRS-1, hence, provides a plausible explanation for
decreased mTOR signaling. Several kinases can induce IRS-1 serine
phosphorylation, including JNK35, IKK36, and well as novel PKCs36,37.
The activation of JNK and IKK is linked to chronic oxidative
and inflammatory stress, as observed with aging. Novel PKCs,
such as PKC-h, are activated by diacylglycerols, which accumulate
when serum free fatty acids increase and mitochondrial function is
defective, both conditions again being met with aging. In agreement
with previous observations38,39, basal AMPK phosphorylation,
reflective of AMPK activation, was not changed with aging, indi-
cating that the defective mitochondrial function observed in aged
tissues does not compromise ATP generation in the basal state.
One of the main goals of our study was to identify novel aging
biomarkers. Therefore, we performed extensive blood and plasma
metabolomics, mainly focusing on nutrient pathways. In this
approach we identified marked changes in amino acid and fatty acid
metabolite levels that could accurately predict aging. Besides blood
metabolomics we also performed an unbiased approach to determine
metabolic changes in aging tissues. Both in muscle and liver, we
identified metabolite sets that are changed upon aging—including
fatty acid and glucose metabolism.
We found glucose and intermediates of glycolysis and glycogen
metabolism, such as maltose and maltotetraose, as biomarkers for
aging in liver as well as muscle (Fig 4–5, 6A). In both liver and
muscle, accumulation of glycogen intermediates suggests altered gly-
cogen metabolism in aged mice, whereas the increased lactate and
reduced glycolytic intermediates suggest elevated anaerobic gly-
colysis. Inmuscle, the elevated levels of glucose, glucose-6-phosphate
and maltose, also suggest changes in glucose and glycogen metabo-
lism (Fig 6A). Indeed, the increase in muscle maltose levels is con-
sistent with increased glycogenolysis. Importantly, these metabolite
data go in pair with the clinical —impaired glucose tolerance— and
signaling —increased IRS-1 serine phosphorylation— data. Elevated
maltose levels were also detected in a recent metabolomics survey of
blood samples from diabetes patients40, again supporting that some
of the metabolic changes we found are linked to aging-related insulin
resistance.
A second pathway that was clearly affected in old mice is fatty acid
metabolism (Fig 6B). Not only did we observe a decrease in gene
expression of genes involved in FAO (Cpt1b in muscle, Acadm in
liver, Acadl in BAT), but also metabolites derived from this pathway
were perturbed. We found plasma free fatty acids to be increased,
whereas plasmamedium and long chain acylcarnitines were lower in
old mice. In contrast, it is well known that during fasting both free
fatty acids as well as medium and long chain acylcarnitines in plasma
increase, reflecting increased FAO flux41. Therefore, our data fit with
reduced entry in and flux through the mitochondrial FAO path-
way42,43, causing an increase in FA levels and a concomitant reduced
‘‘leak’’ of acylcarnitines back into the plasma compartment (dashed
line in Fig 6B). It is important to note that in aged humans, several
fatty acids were also more abundant in plasma22, although no
information is available for acylcarnitines. Our hypotheses also fit
with the accumulation of fatty acids in muscle and with the decrease
in Cpt1b expression in muscle, suggesting a reduced carnitine ester-
ification at the mitochondrial membrane and hence reduced entry
into the mitochondria for FAO. This seems in apparent contradic-
tion with the fact that RER is reduced in old mice —indicative of
increased reliance on fat for energy generation. Indirect calorimetry,
however, measures whole body metabolism and reflects the com-
bination of relative changes in all metabolic pathways (e.g. glucose
and fat oxidation) and all organs (e.g. liver, muscle, etc) that con-
tribute to energy expenditure. Although we cannot exclude tissue-
specific differences in FAO, our data suggest fat metabolism is still
the primary source for ATP generation.
We identified molecular and biochemical profiles of aging in vari-
ous tissues with high predictive accuracy. The cross validation of
these pathways between our various approaches —for instance
FAO metabolites in both blood and tissue metabolomics, and FAO
genes in gene expression— strengthens their potential value as a
biomarker. For biomarker qualification, however, we suggest to ana-
lyze metabolite levels in plasma, as it is easily obtained without the
need of sacrificing the animal or being too invasive in humans.
As discussed above, the changes in plasma free fatty acid and
www.nature.com/scientificreports
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Figure 6 | Models of aging-related changes in glucose and fat metabolism. (A) A summary of the biochemical pathways of glucose metabolism affected
in muscle and liver. Metabolites that changed between young and old are indicated in bold; representative metabolites data from the muscle and liver are
shown in the left and right margin respectively. In summary, accumulation of the glycogen intermediates maltose and maltotetraose suggests increased
liver glycogen breakdown in old mice. On the other hand, increased lactate and reduced glycolysis intermediates suggest elevated glycolysis. Elevated
glucose and glucose-6-phosphate in muscle, in combination with the unchanged lactate levels, suggest decreased glucose disposal in muscle, either by
breakdown or glycogen synthesis. Indeed, the increase inmusclemaltose levels is consistent with increased glycogenolysis. (B) A schematic representation
of fat metabolism, showing representative changes. Plasma triglycerides were decreased, whereas free fatty acids were increased in old mice, suggesting
enhanced triglyceride deposition in tissues, as well as enhanced liberation and/or decreased breakdown of fatty acids. Decreased FAO is supported by
accumulation fatty acid in themuscle, decreased leak of acylcarnitines into plasma (dashed line) and reduced ketogenesis. Decreased Cpt1b expression in
muscle likely contributes to the decreased FAO, also explaining lower plasma acylcarnitine levels. The fact that RER is lower in old mice—indicative for
relative reliance on fat oxidation— suggests that glucose oxidation is also hampered and fat metabolism is still the primary source for ATP generation.
Values are expressed as mean6SEM or as box-and-whisker plots. * p#0.05; ** p#0.01; *** p#0.001.
www.nature.com/scientificreports
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acylcarnitine levels have a high predictive value for separation of
young and old mice, and could prove a strong candidate biomarker
for aging and healthspan. It is also interesting to note that the bio-
synthetic pathway for poly-unsaturated fatty acids was strongly
affected in aged muscle, but similar changes were found in eryth-
rocyte membranes, again proving the value of blood and plasma as a
source for biomarkers. Additionally, measurement of selected
plasma amino acids adds predictive value. Importantly, the relevance
of amino acids as a biomarker was recently corroborated as a com-
bination of several amino acids, including the BCAAs, was associated
with insulin resistance44 and predictive of future diabetes45.We found
some changes in BCAAmetabolites in aged liver and muscle, but not
in plasma, making them less suitable as aging biomarkers.
Even though perhaps less practical from a clinical point of view, a
few additional pathways turned out to be useful to monitor the aging
process and to target by preventive and therapeutic strategies to delay
aging and/or aging-associated pathologies, as they were proven
equally predictive for aging. These include increased tissue oxidative
damage and the accumulation of poly-unsaturated fatty acid inter-
mediates, particularly in themuscle. Additionally, mRNA expression
of a selected set of genes (Cox IV andTfam) was predictive of aging as
it was changed in all tissues tested. In contrast to these biomarkers
that are altered in most of the analyzed tissues, some changes are
indicative of aging in specific tissues, as exemplified by the increased
mitochondrial gene expression and mtDNA content in BAT, per-
haps enabling a better adaptation of this tissue to the metabolic
challenges of aging.
Altogether, our data provide a footprint of metabolic aging in a
well-controlled mammalian system. The pathways that we identified
by our integrative approach also opens up a new avenue of research,
aimed to identify the individual contributions of thesemolecular and
metabolomic systems to the aging process. Although some of these
pathways have already been investigated in relation to aging, further
research is needed to fully establish their relevance, also in man.
Future studies will also have to address how physiological challenges,
such as fasting/feeding, exercise, or high-fat feeding in aged mice
impact on these biomarkers. Additionally, we hope that the iden-
tification of these biomarkers of agingmay spur the rational design of
strategies that can prevent or reverse the decline in certain of the
affected networks and as such could extend healthspan and prevent
accelerated aging.
Methods
Mice. C57BL/6J mice of either 13 weeks old (‘‘young’’) or 93 weeks old (‘‘old’’) were
purchased from Janvier (St. Berthevin, France).Mice were group housed and received
standard chow (#2018, containing 18% protein, 50% carbohydrate and 6.0% fat;
Harlan Laboratories, Madison, WI, USA). After in vivo phenotyping, mice were
sacrificed after overnight fasting, reaching the age of 24 or 103 weeks. Heparinized
plasma was taken and tissues were frozen in liquid nitrogen for biochemical and
molecular analyses.
In vivo phenotyping.Most clinical tests were carried out according to rigorous SOPs
established and validated within the Eumorphia program28,46. Body composition was
determined by Echo-MRI (Echo Medical Systems, Houston, TX, USA) and oxygen
consumption (VO2), respiratory exchange ratios (RER), activity levels and activity
were monitored by indirect calorimetry using the comprehensive laboratory animal
monitoring system (CLAMS) (Columbus Instruments, Columbus, OH, USA)47.
Glucose tolerance was analyzed by measuring blood glucose and insulin following
intraperitoneal injection of 2 g/kg glucose after an overnight fast48. Maximum res-
piration potential (VO2max) was determined in a metabolic treadmill (Columbus
instruments, Columbus, OH, USA) with an incremental speed protocol. During the
run, VO2 and VCO2 are measured. The experiment is stopped when mice are
exhausted, RER is above 1 for more than one interval, or the VO2 reaches a clear
plateau. Voluntary exercise is recorded with a recording running wheel placed in the
home cage for 24h. During that period the mice are individually caged. Gait analysis
was performed using the CatWalk system (Noldus Technology, Wageningen, The
Netherlands)49. Mice were placed for 30 min in a square open field and their move-
ment was recorded using video tracking (Ethovision XT, Noldus Technology,
Wageningen, The Netherlands)50.
Histology and biochemical assays. Mitochondrial complex I and IV activity
(Mitosciences, Eugene, OR, USA), citrate synthase (Sigma) were determined
according to the manufacturer’s protocols. 4-HNE was determined in PBS tissue
lysates using an ELISA-based method (Cell Biolabs, San Diego, CA, USA). Western
blotting was performed as described before2. Additional antibodies include Tubulin
(Santa Cruz Biotechnology), p-Ser (Sigma), p-ACC (Millipore), IRS-1, p-AMPKa,
AMPKa, S6K1 and p-S6K1 (Cell Signaling Technology)51.
Gene expression and mitochondrial DNA abundance. RNA was extracted from
tissues using Trizol. cDNA was synthesized using the QuantiTect RT kit (Qiagen),
followed by qPCR on a Roche Lightcycler 480 and using Roche SYBR-green mas-
termix. qPCR primers are described in the Extended Experimental Procedures.
Mitochondrial DNA abundance (mtDNA) was quantified as described before47. In
short, DNA was extracted using a standard phenol extraction, and the resulting
genomic DNA (gDNA) was used for qPCR using the primers in the Extended
Experimental Procedures. Microarray data from gastrocnemius muscle of C57BL/6N
mice of either 5 months (young), 25 months (old) or CR diet21, were retrieved from
the public Gene Aging Nexus database (http://gan.usc.edu/public/index.jsp)52.
Plasma biochemistry and targeted metabolomics. Basic plasma clinical chemistry
analyses were performed according to Eumorphia SOPs28,46. Plasma acylcarnitines
and amino acids were determined by tandem mass spectrometry (MSn) and LC-MSn
respectively53,54. Fatty acids in erythrocytes were directly transesterified and analyzed
by gas chromatography with flame ionization detection55. Beta-hydroxybutyric acid
was measured in perchloric acid deproteinized plasma using established procedures56
Global metabolomics. Metabolomics of quadriceps muscle and liver of young and
old mice (8 and 7 mice per group, respectively) was performed by Metabolon
(Durham, NC, USA), according to published methods57. In brief, sample preparation
was conducted using a proprietary series of organic and aqueous extractions to
remove the protein fraction while allowing maximum recovery of small molecules.
The extracted samples were split into equal parts for analysis on the GC/MS and LC-
MS/MS platforms. For LC-MS/MS, samples were split in two aliquots that were either
analyzed in positive (acidic solvent) or negative (basic solvent) ionization mode. GC-
MS was performed on bistrimethyl-silyl-triflouroacetamide derivatized samples in a
5% phenyl GC column.
Bioinformatics and statistics.Data in figures is presented as mean6SEM or as box-
and-whisker plots indicating the sample minimum, lower quartile, median, upper
quartile, and sample maximum with outliers represented as small circles. A Students
T-test or Welch’s T-test (liver and muscle metabolomics data) was performed for
statistical comparison between young and old mice. A p-value of 0.05 or less was
considered significant.
Unsupervised hierarchical clustering was performed using complete linkage and
Pearson rank correlation distance on the normalized metabolites using software
implemented in Genepattern (http://www.broadinstitute.org/cancer/software/gene-
pattern/)58,59. The z-score was calculated by subtracting themean expression value for
each metabolite from each of the values and then dividing the resulting values by the
standard deviation. Color in the heat-maps reflects the relative metabolite abundance
level with red being higher and blue lower than themeanmetabolite abundance value.
Metabolite and animal ordering is determined as in hierarchical clustering using the
distance function 1-correlation.
The web-based metabolomic data processing tool, MetaboAnalyst60 was used for
tissue metabolite data analysis. See http://www.metaboanalyst.ca for detailed meth-
odology. Briefly, for the RF analysis, the metabolite data was log transformed (log 2)
and the number of predictors to try for each nodewas set to the square root of the total
number of variables per tissue and the number of trees to growwas set to 10.000. RF is
performed using the random forest package and the resulting confusionmatrix, out of
bag (OOB) error and variable importance (as determined by the mean decrease in
accuracy when data is permuted) are presented. For MSEA, metabolite data was
mapped according to HMDB and the ‘Metabolite pathway associated metabolite set’
library (currently 88 entries) was chosen for the enrichment analysis, which is per-
formed using package global test. The metabolome view displays the pathway topo-
logical analysis, a method that takes into account the pathway structure when
determining which pathways are more likely to be of significance. The parameters
chosen for this analysis included global test and the node centrality measure
‘betweenness centrality’ to estimate node importance. This measure considers the
global network structure such that nodes that occur between two dense clusters will
have a high betweenness centrality even if its degree centrality is not high. The node
importance values calculated from centrality measures are further normalized by the
sum of the importance of the pathway for comparison among different pathways.
Therefore, the total/maximum importance of each pathway is 1; the importance
measure of each metabolite node is actually the percentage with respect to the total
pathway importance, and the pathway impact is the cumulative percentage from the
matched metabolite nodes.
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